Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AA NABPLAGEM in Untreated Metastatic Pancreatic Cancer
NCT03908333Phase 2Withdrawn
- Sponsor
- Medical College of Wisconsin
- Start
- May 2019
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ascorbic acid in pancreatic cancer (PC), sponsored by Medical College of Wisconsin. Planned start May 2019; status: withdrawn.
02
Drugs
ascorbic acid
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT03908333.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03908333.